Decision to list medical devices in the surgical suction, chest and wound drainage category supplied by Getinge Australia Pty Ltd
Source: Pharmac Our response to what you told us We appreciate the time people took to respond to this consultation. A summary of the main themes raised in feedback and our responses to the feedback received are set out below: Theme Comment Feedback that no technical or resource impacts are expected as a result of […]
Read More →Proposal to amend or list medical devices supplied by Boucher & Muir (NZ) Ltd
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to amend current listings and extend the range of insulin pen needles supplied by Boucher & Muir (NZ) Ltd (“Boucher & Muir”), through a non-exclusive provisional agreement. It is proposed that: from 1 June 2019 Boucher & Muir’s brand of insulin pen needle […]
Read More →Proposal to list interventional radiology products supplied by Stryker New Zealand Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of medical devices in the interventional radiology consumable products category in Part III of Section H of the Pharmaceutical Schedule from 1 May 2019, though a listing agreement with Stryker New Zealand Limited (“Stryker”). Consultation closes at 4pm on […]
Read More →Decision to list patient warming and cooling medical devices supplied by EBOS Group Limited and Surgico Medical & Surgical Limited
Source: Pharmac Detail about this decision PHARMAC issued Requests for Proposals (“RFP”) patient warming and cooling products. The RFP was for non-exclusive national agreements for listing in the Pharmaceutical Schedule. After completing the RFP evaluation process and consulting on the provisional Agreements reached with EBOS and Surgico PHARMAC has decided to list EBOS and Surgico’s range […]
Read More →Decision to award market share for permanent coronary drug eluting stents to Abbott Laboratories NZ Limited
Source: Pharmac What we are doing We are pleased to announce the approval to award Hospital Supply Status (“HSS”) to Abbott Laboratories NZ Limited (“Abbott”) for the supply of permanent coronary drug eluting stents to DHBs, with a 35% Discretionary Variance (“DV”) Limit. The HSS will apply from 1 August 2019 until 30 June 2022. […]
Read More →Decision to make changes to funded haemophilia treatments
Source: Pharmac What we’re doing We’re pleased to announce changes to funded haemophilia treatments that will result in two new extended half-life treatments being funded for the first time in New Zealand. These extended half-life treatments will be funded for all people requiring prophylaxis treatment and are expected to provide prolonged protection from bleeding and […]
Read More →Decision to list continence products supplied by Asaleo Care New Zealand Limited
Source: Pharmac Detail about this decision In May 2018, PHARMAC issued a request for proposals (“RFP”) for the supply of urology, ostomy and continence products to DHBs. The RFP requested proposals for non-exclusive national agreements for listing on the Pharmaceutical Schedule. After evaluating Asaleo’s proposal, and consulting on the provisional agreement, PHARMAC has decided to […]
Read More →Decision to list respiratory care products supplied by MedXus Limited
Source: Pharmac What we are doing We are pleased to announce a listing agreement with MedXus Limited (“MedXus”) for the supply of respiratory equipment and consumables to DHB Hospitals. In summary this will result in: MedXus’ respiratory equipment and consumables being listed on the Pharmaceutical Schedule from 1 April 2019 under a national agreement that all […]
Read More →Decision to list needles and syringes products supplied by Culpan Distributors Ltd and Universal Specialities Limited (USL Medical)
Source: Pharmac What we are doing We are pleased to announce the approval of two non-exclusive listing agreements (“Agreements”) with Culpan Distributors Ltd (“Culpan”) and Universal Specialities Limited (“USL Medical”) for the supply of needle and syringe products to DHBs. In summary this will result in: Culpan’s needle and syringe products being listed in Part […]
Read More →Decision to list medical devices
Source: Pharmac Detail about this decision PHARMAC issued Requests for Proposals (“RFPs”) for: The RFP was for non-exclusive national agreements for listing in the Pharmaceutical Schedule. After completing the RFP evaluation processes and consulting on the provisional Agreements reached with 3M, Big Green Surgical, Mӧlnlycke, NZMS and W M Bamford PHARMAC has decided to list […]
Read More →OIA responses: exploring ways to publish them
Source: Pharmac This new section of our News is a test of how we might publish responses to requests under the Official Information Act so they’re easy to read and use. We’re also working on ways to publish more complicated responses. Our accountability page has the Government’s expectations of us, how we intend to meet […]
Read More →Proposal to list patient warming and cooling medical devices supplied by EBOS Group Limited and Surgico Medical & Surgical Ltd
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of patient warming and cooling products in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019 through provisional agreements with EBOS Group Limited (“EBOS”) and Surgico Medical & Surgical Ltd (“Surgico”). Consultation closes at 4pm […]
Read More →Proposal to list respiratory care products supplied by MedXus Limited
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of respiratory equipment and consumable devices (“respiratory care products”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019, through a provisional agreement with MedXus Limited (“MedXus). Consultation closes at 4pm on Thursday, 28 February 2019 and feedback […]
Read More →Proposal to list surgical suction, chest and wound drainage products
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of surgical suction, chest and wound drainage products in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019 through provisional amendments to the Agreements with Conva Tec (New Zealand) Limited (“Conva Tec”), Defries Industries NZ […]
Read More →January 2019 tender notification
Source: Pharmac 31 January 2019 PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2017/18 Invitation to Tender, dated 2 November 2017. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject […]
Read More →Proposal to list medical devices supplied by Universal Specialities Limited (USL Medical)
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of needles and syringes in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019, through a non-exclusive provisional agreement with Universal Specialities Limited (“USL Medical”). Consultation closes at 4pm on Wednesday, 20 February 2019 and feedback can […]
Read More →Proposal for changes to funded haemophilia treatments
Source: Pharmac We are proposing to make changes to the funding of haemophilia treatments from 1 May 2019, including funding of new extended half-life treatments. These changes would mean that most people with haemophilia would need to change brands, but there would be an increase in the range of funded treatment options available with extended-half-life […]
Read More →Proposal to list medical devices
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019. We propose to list medical devices supplied by: Supplier Category of Medical Device 3M New Zealand Limited (“3M”) Endomechanical and electrosurgical Patient warming and cooling […]
Read More →Proposal to list medical devices supplied by Culpan Distributors Ltd
Source: Pharmac What we’re proposing PHARMAC is seeking feedback on a proposal to list a range of needles and syringes in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019, through a provisional agreement with Culpan Distributors Ltd (“Culpan”). Consultation closes at 4pm on Thursday, 13 February 2019 and feedback can be emailed […]
Read More →Decision to list needles and syringes products supplied by B. Braun New Zealand Pty Limited
Source: Pharmac What we are doing We are pleased to announce a listing agreement with B. Braun New Zealand Pty Limited (“B. Braun”) for the supply of needles and syringes products to DHBs. In summary this will result in: B. Braun’s needles and syringes products being listed on the Pharmaceutical Schedule from 1 March 2019 under […]
Read More →